Skip to content

En español

Author Archive

How Breast Cancer Drugs Are Developed: The Bazedoxifene Story

By on August 13th, 2013 Categories: Research News, Treatment & Side Effects

Many of you may have read a news story about bazedoxifene (BZA), a SERM (selective estrogen receptor modulator) approved in Europe to treat osteoporosis that has been shown to stop the growth of hormone-receptor-positive breast cancer cells, even in cancers that had become resistant to tamoxifen or the aromatase inhibitors.

Women in this situation are wondering if they can try BZA – either prescribed by …

Back to top

Breastcancer.org is a non-profit organization dedicated to providing information and community to those touched by this disease. Learn more about our commitment to providing complete, accurate, and private breast cancer information.

Breastcancer.org 7 East Lancaster Avenue, 3rd Floor Ardmore, PA 19003

© 2014 Breastcancer.org - All rights reserved.